Article
Exploring the Role of Antibody-Drug Conjugates in Non–Small Cell Lung Cancer
ON SEPTEMBER 11, 2022, OncLive® brought together medical oncologists who specialize in the treatment of non–small cell lung cancer (NSCLC). Moderated by Grace K. Dy, MD, the objectives of the workshop were to evaluate the potential role and impact of new antibody-drug conjugates (ADCs) in the treatment of patients with NSCLC.
Latest CME
View All
Video
(CME Track) Clinical Consultations™: Framing a New Approach to Geographic Atrophy Management – Expert Insights into Recent Developments
Apr 23rd 2025 - Apr 24th 2026
online-activity
Video
Optimizing Today and Looking to Tomorrow in Metastatic CRPC—Homing in on EZH2
Apr 23rd 2025 - Apr 24th 2026
online-activity
Video
Addressing Unmet Needs in HER2+ Metastatic BTC
Apr 18th 2025 - Apr 19th 2026
online-activity
Related Content
.png?fit=crop&auto=format)
